These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 6747299)
1. Modulation by recombinant DNA leukocyte (alpha) and fibroblast (beta) interferons of the expression and shedding of HLA- and tumor-associated antigens by human melanoma cells. Giacomini P; Aguzzi A; Pestka S; Fisher PB; Ferrone S J Immunol; 1984 Sep; 133(3):1649-55. PubMed ID: 6747299 [TBL] [Abstract][Full Text] [Related]
2. Immunochemical analysis of the modulation of human melanoma-associated antigens by DNA recombinant immune interferon. Giacomini P; Imberti L; Aguzzi A; Fisher PB; Trinchieri G; Ferrone S J Immunol; 1985 Oct; 135(4):2887-94. PubMed ID: 3928760 [TBL] [Abstract][Full Text] [Related]
3. Modulation by interferons of HLA antigen, high-molecular-weight melanoma associated antigen, and intercellular adhesion molecule 1 expression by cultured melanoma cells with different metastatic potential. Maio M; Gulwani B; Langer JA; Kerbel RS; Duigou GJ; Fisher PB; Ferrone S Cancer Res; 1989 Jun; 49(11):2980-7. PubMed ID: 2497970 [TBL] [Abstract][Full Text] [Related]
4. Regulation of the antigenic phenotype of human melanoma cells by recombinant interferons. Giacomini P; Gambari R; Barbieri R; Nisticò P; Tecce R; Pestka S; Gustafsson K; Natali PG; Fisher PB Anticancer Res; 1986; 6(5):877-84. PubMed ID: 2432832 [TBL] [Abstract][Full Text] [Related]
5. Effect of recombinant human fibroblast interferon and mezerein on growth, differentiation, immune interferon binding and tumor associated antigen expression in human melanoma cells. Fisher PB; Hermo H; Solowey WE; Dietrich MC; Edwalds GM; Weinstein IB; Langer JA; Pestka S; Giacomini P; Kusama M Anticancer Res; 1986; 6(4):765-74. PubMed ID: 2944474 [TBL] [Abstract][Full Text] [Related]
6. Increased surface expression and shedding of tumor associated antigens by human breast carcinoma cells treated with recombinant human interferons or phorbol ester tumor promoters. Leon JA; Mesa-Tejada R; Gutierrez MC; Estabrook A; Greiner JW; Schlom J; Fisher PB Anticancer Res; 1989; 9(6):1639-47. PubMed ID: 2516715 [TBL] [Abstract][Full Text] [Related]
7. Differential modulation by recombinant immune interferon of the expression and shedding of HLA antigens and melanoma associated antigens by a melanoma cell line resistant to the antiproliferative activity of immune interferon. Ziai MR; Imberti L; Tongson A; Ferrone S Cancer Res; 1985 Nov; 45(11 Pt 2):5877-82. PubMed ID: 3931909 [TBL] [Abstract][Full Text] [Related]
8. Recombinant interferon-gamma can induce the expression of HLA-DR and -DC on DR-negative melanoma cells and enhance the expression of HLA-ABC and tumor-associated antigens. Carrel S; Schmidt-Kessen A; Giuffrè L Eur J Immunol; 1985 Feb; 15(2):118-23. PubMed ID: 3918869 [TBL] [Abstract][Full Text] [Related]
9. Differential effects of recombinant human leukocyte interferons on cell surface antigen expression. Greiner JW; Fisher PB; Pestka S; Schlom J Cancer Res; 1986 Oct; 46(10):4984-90. PubMed ID: 2944575 [TBL] [Abstract][Full Text] [Related]
10. Classes I and II HLA and melanoma-associated antigen expression and modulation on melanoma cells isolated from primary and metastatic lesions. Taramelli D; Fossati G; Mazzocchi A; Delia D; Ferrone S; Parmiani G Cancer Res; 1986 Jan; 46(1):433-9. PubMed ID: 3079589 [TBL] [Abstract][Full Text] [Related]
11. Effect of recombinant human leukocyte, fibroblast, and immune interferons on expression of class I and II major histocompatibility complex and invariant chain in early passage human melanoma cells. Nisticò P; Tecce R; Giacomini P; Cavallari A; D'Agnano I; Fisher PB; Natali PG Cancer Res; 1990 Dec; 50(23):7422-9. PubMed ID: 1701342 [TBL] [Abstract][Full Text] [Related]
12. Immunochemical and functional analysis of HLA class II antigens induced by recombinant immune interferon on normal epidermal melanocytes. Tsujisaki M; Igarashi M; Sakaguchi K; Eisinger M; Herlyn M; Ferrone S J Immunol; 1987 Feb; 138(4):1310-6. PubMed ID: 3100635 [TBL] [Abstract][Full Text] [Related]
13. Differential in vitro effects of recombinant alpha-interferon and recombinant gamma-interferon alone or in combination on the expression of melanoma-associated surface antigens. Murray JL; Stuckey SE; Pillow JK; Rosenblum MG; Gutterman JU J Biol Response Mod; 1988 Apr; 7(2):152-61. PubMed ID: 3129542 [TBL] [Abstract][Full Text] [Related]
14. Enhanced expression of melanoma-associated antigens and beta 2-microglobulin on cultured human melanoma cells by interferon. Liao SK; Kwong PC; Khosravi M; Dent PB J Natl Cancer Inst; 1982 Jan; 68(1):19-25. PubMed ID: 6172626 [TBL] [Abstract][Full Text] [Related]
15. HLA-DR synthesis induction and expression in HLA-DR-negative carcinoma cell lines of diverse origins by interferon-gamma but not by interferon-beta. Shaw AR; Chan JK; Reid S; Seehafer J J Natl Cancer Inst; 1985 Jun; 74(6):1261-8. PubMed ID: 3923246 [TBL] [Abstract][Full Text] [Related]
16. Heterogeneous expression of melanoma-associated antigens and HLA antigens by primary and multiple metastatic lesions removed from patients with melanoma. Natali P; Bigotti A; Cavaliere R; Liao SK; Taniguchi M; Matsui M; Ferrone S Cancer Res; 1985 Jun; 45(6):2883-9. PubMed ID: 3157450 [TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of HLA-A,B, Ia-like, and melanoma-associated antigen expression by human melanoma cell lines analyzed with monoclonal antibodies and flow cytometry. Burchiel SW; Martin JC; Imai K; Ferrone S; Warner NL Cancer Res; 1982 Oct; 42(10):4110-5. PubMed ID: 7049355 [TBL] [Abstract][Full Text] [Related]
19. Phenotyping of lesions of melanocyte origin with monoclonal antibodies to melanoma-associated antigens and to HLA antigens. Natali PG; Bigotti A; Cavaliere R; Nicotra MR; Ferrone S J Natl Cancer Inst; 1984 Jul; 73(1):13-24. PubMed ID: 6376904 [TBL] [Abstract][Full Text] [Related]
20. Analysis of receptors, cell surface antigens, and proteins in human melanoma cell lines resistant to human recombinant beta- or gamma-interferon. Gomi K; Akinaga S; Oka T; Morimoto M Cancer Res; 1986 Dec; 46(12 Pt 1):6211-6. PubMed ID: 2430691 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]